Teva Pharmaceutical Industries (TEVA) Inventory (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Inventory came in at $3.2 billion in Q2 2026, down 7.89% YoY from $3.5 billion in Q2 2025, and up 1.42% on a QoQ basis from $3.2 billion in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Inventory (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Inventory data on file, last reported at $3.2 billion in Q2 2026.
- Quarterly Inventory fell 7.89% year-over-year to $3.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.2 billion (down 7.89% YoY) and the FY2025 annual result came in at $3.2 billion, up 5.72% from the prior year.
- Inventory grew to $3.2 billion in Q2 2026, from $3.2 billion in the prior quarter.
- In the past five years, Inventory ranged from a high of $4.1 billion in Q1 2023 to a low of $3.0 billion in Q4 2024.
- A 5-year average of $3.7 billion and a median of $3.9 billion in 2022 frame the typical range for Inventory.
- Annual changes were most pronounced in 2024 — Inventory dropped 25.22% — and 2025, when it rose 5.72%.
- Tracing TEVA's Inventory over 5 years: stood at $3.8 billion in 2022, then grew by 4.9% to $4.0 billion in 2023, then dropped by 25.22% to $3.0 billion in 2024, then rose by 5.72% to $3.2 billion in 2025, then grew by 1.32% to $3.2 billion in 2026.
- The last three Inventory figures came in at $3.2 billion (Q2 2026), $3.2 billion (Q1 2026), and $3.2 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 816.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 298.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.22 Bn |
| Mar 31, 2026 | 3.18 Bn |
| Dec 31, 2025 | 3.18 Bn |
| Sep 30, 2025 | 3.32 Bn |
| Jun 30, 2025 | 3.50 Bn |
| Mar 31, 2025 | 3.25 Bn |
| Dec 31, 2024 | 3.01 Bn |
| Sep 30, 2024 | 3.96 Bn |
| Jun 30, 2024 | 3.93 Bn |
| Mar 31, 2024 | 3.95 Bn |
| Dec 31, 2023 | 4.02 Bn |
| Sep 30, 2023 | 4.05 Bn |
| Jun 30, 2023 | 4.11 Bn |
| Mar 31, 2023 | 4.12 Bn |
| Dec 31, 2022 | 3.83 Bn |
| Sep 30, 2022 | 3.86 Bn |
| Jun 30, 2022 | 4.05 Bn |
| Mar 31, 2022 | 4.01 Bn |
| Dec 31, 2021 | 3.82 Bn |
| Sep 30, 2021 | 4.17 Bn |